Conteltinib is a small molecule tyrosine kinase inhibitor under investigation in clinical trials. It is a pharmaceutical raw material used in research for advanced solid tumors with specific genetic mutations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Conteltinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexan-1-ol--hydrogen chloride (1/1)
pharmaceutical raw material
Dexlansoprazole
pharmaceutical raw material
4-Amino-2-methyl-10H-thiene[2,3-b][1,5]benzodiazepine hydrochloride
pharmaceutical raw material
Icatibant acetate
pharmaceutical raw material
The international HS code for Conteltinib (CAS 1384860-29-0) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[[2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-propan-2-ylbenzenesulfonamide
NPJCURIANJMFEO-UHFFFAOYSA-N
CC(C)NS(=O)(=O)C1=CC=CC=C1NC2=NC(=NC3=C2CCN3)NC4=C(C=C(C=C4)N5CCC(CC5)N6CCN(CC6)C)OC
Sourcing Conteltinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.